Evidence map›Paper›PMID 37417957›Full record

ArticleeLife2023

Vitamin B2 enables regulation of fasting glucose availability.

Peter M Masschelin, Pradip Saha, Scott A Ochsner, Aaron R Cox, Kang Ho Kim, Jessica B Felix, Robert Sharp, Xin Li, Lin Tan, Jun Hyoung Park and 11 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Peter M MasschelinDepartment of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, United States.
Pradip SahaDepartment of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, United States.
Scott A OchsnerDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States.
Aaron R CoxDepartment of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, United States.
Kang Ho KimDepartment of Anesthesiology, University of Texas Health Sciences Center, Houston, United States.
Jessica B FelixDepartment of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, United States.
Robert SharpDepartment of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, United States.
Xin LiDepartment of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, United States.ORCID 0000-0002-7325-4250
Lin TanDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Jun Hyoung ParkDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States.
Liping WangDepartment of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, United States.ORCID 0000-0003-3537-0952
Vasanta PutluriDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States.
Philip L LorenziDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, United States.ORCID 0000-0003-0385-7774
Alli M Nuotio-AntarDepartment of Pediatrics, Baylor College of Medicine, Houston, United States.ORCID 0000-0002-1830-4868
Zheng SunDepartment of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, United States.ORCID 0000-0002-6858-0633
Benny Abraham KaipparettuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States.
Nagireddy PutluriDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States.
David D MooreDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States.
Scott A SummersDepartment of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, United States.
Neil J McKennaDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States.
Sean M HartigDepartment of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, United States.ORCID 0000-0002-2695-2072
Baylor College of Medicine · USThe University of Texas MD Anderson Cancer Center · USUniversity of Utah · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Suzanne AW Fuqua · 2007 to 2026
$73.9M
Translational Research Support CoreP30ES030285 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Cheryl L. Walker · 2019 to 2026
$14.7M
Initiative for Maximizing Student Development (IMSD) ProgramR25GM056929 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI PEREIRA, FRED A · 1998 to 2023
$12.4M
METABOLIC IMPACTS OF TYPE II INTERFERON SIGNALS IN OBESITYR01DK114356 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI HARTIG, SEAN · 2017 to 2025
$4.6M
The Role of Ceramides in Skeletal MuscleR01DK115824 · NIDDK · UNIVERSITY OF UTAH · PI SUMMERS, SCOTT A · 2018 to 2021
$2.6M
The Role of Ceramides in the Intestinal Stem CellR01DK131609 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI EDGAR, BRUCE ALEXANDER, SUMMERS, SCOTT A · 2021 to 2025
$2.5M
The Role of Ceramides in the Pancreatic Beta CellR01DK130296 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI HOLLAND, WILLIAM L, SUMMERS, SCOTT A · 2022 to 2025
$2.2M
Targeting a Ceramide Double Bond to Treat Cardiometabolic DisordersR01DK122001 · NIDDK · UNIVERSITY OF UTAH · PI SUMMERS, SCOTT A · 2019 to 2022
$1.9M
Baylor College of Medicine Initiative for Maximizing Student DevelopmentT32GM152777 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI PANGAS, STEPHANIE A., PEREIRA, FRED A · 2024 to 2024
$547k
NCI NIH HHS P30 CA125123NIDDK NIH HHS R01 DK114356NIDDK NIH HHS R01DK114356NIDDK NIH HHS R01 DK115824NIDDK NIH HHS R01 DK122001NIDDK NIH HHS R01 DK130296NIDDK NIH HHS R01 DK131609NIGMS NIH HHS R25 GM056929NIGMS NIH HHS T32 GM152777
6 · The paper itself

Abstract

Flavin adenine dinucleotide (FAD) interacts with flavoproteins to mediate oxidation-reduction reactions required for cellular energy demands. Not surprisingly, mutations that alter FAD binding to flavoproteins cause rare inborn errors of metabolism (IEMs) that disrupt liver function and render fasting intolerance, hepatic steatosis, and lipodystrophy. In our study, depleting FAD pools in mice with a vitamin B2-deficient diet (B2D) caused phenotypes associated with organic acidemias and other IEMs, including reduced body weight, hypoglycemia, and fatty liver disease. Integrated discovery approaches revealed B2D tempered fasting activation of target genes for the nuclear receptor PPARα, including those required for gluconeogenesis. We also found PPARα knockdown in the liver recapitulated B2D effects on glucose excursion and fatty liver disease in mice. Finally, treatment with the PPARα agonist fenofibrate activated the integrated stress response and refilled amino acid substrates to rescue fasting glucose availability and overcome B2D phenotypes. These findings identify metabolic responses to FAD availability and nominate strategies for the management of organic acidemias and other rare IEMs.

Indexed as

GlucoseNon-alcoholic Fatty Liver DiseaseAnimalsFastingFatty AcidsFlavin-Adenine DinucleotideFlavoproteinsLiverMiceOxidation-ReductionPPAR alphaFatty AcidsFlavin-Adenine DinucleotideFlavoproteinsGlucosePPAR alphacell biologyFADgluconeogenesisinborn errors of metabolismmetabolismmousenuclear receptor

Identifiers

PMID37417957
PMCPMC10328530
OpenAlexW4383482902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.